Virgotech Expands Operations to South Korea and Germany

Virgotech is proud to announce the formal expansion of its biotechnology consulting and project development services to two new markets — South Korea and Germany — marking a significant milestone in our mission to deliver sustainable biotechnology solutions across the world.

The expansion into South Korea represents Virgotech's first formal presence in the nation. With South Korea's rapidly growing biotechnology sector and its position as a gateway to broader Asian markets, this move aligns perfectly with our long-term strategic vision. Our South Korean operations will focus primarily on agricultural biotechnology — including sustainable farming solutions, bio-fertilizer development and crop disease management programs.

Germany, as one of Europe's leading biotechnology markets and home to a highly sophisticated research and development ecosystem, represents an equally exciting opportunity. Virgotech's German operations will focus on industrial biotechnology — particularly bioprocess development, enzyme engineering and biodegradable materials research in partnership with German academic and industry institutions.

"This expansion is a natural evolution of Virgotech's global ambitions," said Founder and CEO Gary Theodore Wagner. "Both South Korea and Germany represent markets where our expertise can make a real and lasting impact — and where the demand for innovative, nature-based biotechnology solutions is growing rapidly."

Virgotech now operates across 11+ countries including the USA, Canada, Thailand, China, Russia, Brazil, UAE, the United Kingdom, South Africa, South Korea and Germany. Our global reach continues to grow as we pursue our mission of simulating nature to build a better world.